Skip to search formSkip to main contentSkip to account menu

c-Met Inhibitor MSC2156119J

Known as: MSC2156119J 
An orally bioavailable inhibitor of the proto-oncogene c-Met (also known as hepatocyte growth factor receptor (HGFR)) with potential antineoplastic… 
National Institutes of Health

Search for papers about c-Met Inhibitor MSC2156119J

Search papers